Hot Features
Sera Prognostics, Inc., a women’s health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetu... Sera Prognostics, Inc., a women’s health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.075 | -3.42465753425 | 2.19 | 2.33 | 1.96 | 45566 | 2.1781472 | CS |
| 4 | 0.375 | 21.5517241379 | 1.74 | 2.3699 | 1.56 | 80853 | 1.99171205 | CS |
| 12 | 0.035 | 1.68269230769 | 2.08 | 2.3699 | 1.56 | 58113 | 1.97886046 | CS |
| 26 | -0.905 | -29.9668874172 | 3.02 | 3.85 | 1.56 | 59663 | 2.44680793 | CS |
| 52 | 0.565 | 36.4516129032 | 1.55 | 4.09 | 1.37 | 126921 | 2.92277983 | CS |
| 156 | -1.145 | -35.1226993865 | 3.26 | 12.355 | 1.37 | 246788 | 5.31174268 | CS |
| 260 | -12.895 | -85.9093937375 | 15.01 | 15.5 | 1.1 | 242794 | 4.53231158 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.